Zobrazeno 1 - 10
of 398
pro vyhledávání: '"Lori J. Pierce"'
Autor:
Anna R. Michmerhuizen, Lynn M. Lerner, Andrea M. Pesch, Connor Ward, Rachel Schwartz, Kari Wilder-Romans, Meilan Liu, Charles Nino, Kassidy Jungles, Ruth Azaria, Alexa Jelley, Nicole Zambrana Garcia, Alexis Harold, Amanda Zhang, Bryan Wharram, Daniel F. Hayes, James M. Rae, Lori J. Pierce, Corey W. Speers
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract Endocrine therapy (ET) is an effective first-line therapy for women with estrogen receptor-positive (ER + ) breast cancers. While both ionizing radiation (RT) and ET are used for the treatment of women with ER+ breast cancer, the most effect
Externí odkaz:
https://doaj.org/article/dcd32144b036459fac1d9db7b328ac9f
Autor:
Kassidy M. Jungles, Erin A. Holcomb, Ashley N. Pearson, Kalli R. Jungles, Caroline R. Bishop, Lori J. Pierce, Michael D. Green, Corey W. Speers
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Breast cancer is the most prevalent non-skin cancer diagnosed in females and developing novel therapeutic strategies to improve patient outcomes is crucial. The immune system plays an integral role in the body’s response to breast cancer and modula
Externí odkaz:
https://doaj.org/article/a1646c8108df4ebaa89b58f28bc101db
Autor:
Andrea M. Pesch, Nicole H. Hirsh, Anna R. Michmerhuizen, Kassidy M. Jungles, Kari Wilder-Romans, Benjamin C. Chandler, Meilan Liu, Lynn M. Lerner, Charles A. Nino, Connor Ward, Erin F. Cobain, Theodore S. Lawrence, Lori J. Pierce, James M. Rae, Corey W. Speers
Publikováno v:
JCI Insight, Vol 7, Iss 3 (2022)
Standard radiation therapy (RT) does not reliably provide locoregional control for women with multinode-positive breast cancer and triple-negative breast cancer (TNBC). We hypothesized that CDK4/6 inhibition (CDK4/6i) would increase the radiosensitiv
Externí odkaz:
https://doaj.org/article/a01908851a6948f19c0bebb697957f52
Autor:
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander, S. Laura Chang, Felix Y. Feng, Corey W. Speers, Lori J. Pierce, Anikó Kovács, Dan Lundstedt, Erik Holmberg, Per Karlsson
Publikováno v:
Clinical Cancer Research. 29:1783-1793
Purpose: The local immune infiltrate's influence on tumor progression may be closely linked to tumor-intrinsic factors. The study aimed to investigate whether integrating immunologic and tumor-intrinsic factors can identify patients from a low-risk c
Autor:
Carmen Guerra, Alice Pressman, Patricia Hurley, Elizabeth Garrett-Mayer, Suanna S. Bruinooge, Alexandra Howson, Melinda Kaltenbaugh, Jen Hanley Williams, Leigh Boehmer, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Lola Fashoyin-Aje, Worta McCaskill-Stevens, Janette Merrill, Greg Nowakowski, Manali I. Patel, Amelie Ramirez, Victoria Zwicker, Randall A. Oyer, Lori J. Pierce
Publikováno v:
JCO Oncology Practice. 19:e581-e588
Clinical trial participants do not reflect the racial and ethnic diversity of people with cancer. ASCO and the Association of Community Cancer Centers collaborated on a quality improvement study to enhance racial and ethnic equity, diversity, and inc
Autor:
Anna R. Michmerhuizen, Lynn M. Lerner, Andrea M. Pesch, Connor Ward, Rachel Schwartz, Kari Wilder-Romans, Meilan Liu, Charles Nino, Kassidy Jungles, Ruth Azaria, Alexa Jelley, Nicole Zambrana Garcia, Alexis Harold, Amanda Zhang, Bryan Wharram, Daniel F. Hayes, James M. Rae, Lori J. Pierce, Corey W. Speers
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/549150630d4b476a9dff4be90f0aa8ea
Publikováno v:
Practical Radiation Oncology. 13:e121-e125
Autor:
Anna R. Michmerhuizen, Benjamin Chandler, Eric Olsen, Kari Wilder-Romans, Leah Moubadder, Meilan Liu, Andrea M. Pesch, Amanda Zhang, Cassandra Ritter, S. Tanner Ward, Alyssa Santola, Shyam Nyati, James M. Rae, Daniel Hayes, Felix Y. Feng, Daniel Spratt, Daniel Wahl, Joel Eisner, Lori J. Pierce, Corey Speers
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Increased rates of locoregional recurrence (LR) have been observed in triple negative breast cancer (TNBC) despite multimodality therapy, including radiation (RT). Recent data suggest inhibiting the androgen receptor (AR) may be an effective radiosen
Externí odkaz:
https://doaj.org/article/a54f32bc80444bdc91e0c360229a5391
Autor:
Corey Speers, Shuang G. Zhao, Ben Chandler, Meilan Liu, Kari Wilder-Romans, Eric Olsen, Shyam Nyati, Cassandra Ritter, Prasanna G. Alluri, Vishal Kothari, Daniel F. Hayes, Theodore S. Lawrence, Daniel E. Spratt, Daniel R. Wahl, Lori J. Pierce, Felix Y. Feng
Publikováno v:
npj Breast Cancer, Vol 3, Iss 1, Pp 1-10 (2017)
Radiation: Drug target found for radioresistance Drugs that block the androgen receptor (AR) protein can help make radiation-resistant breast tumors susceptible to ionizing therapy. Corey Speers from the University of Michigan, Ann Arbor, USA, and co
Externí odkaz:
https://doaj.org/article/c2e0158317ef4f30b527bc09f5771091
Publikováno v:
Cancer. 128:3278-3283
Although Medicaid Expansion under the Patient Protection and Affordable Care Act (ACA) has been associated with many improvements for patients with cancer, Snyder et al. provide evidence demonstrating the persistence of racial disparities in cancer.